European startup finance is sending two apparently conflicting signals. Capital has recovered, but the number of companies receiving it has fallen to a six-year low in one widely reported deal-count series. Artificial intelligence is taking a large share of investor attention and money, producing a market in which strong headline totals conceal a narrower path to funding.
Tech.eu’s separate H1 2026 dataset recorded €44.1 billion invested across just over 1,740 deals. That compares with €50.1 billion and about 2,000 deals in the first half of 2024. Funding fell by more than 30 percent in H1 2025 while deal activity remained broadly stable, then capital rebounded this year as transaction volume contracted. Different databases use different definitions, but they describe the same direction: larger cheques are going to fewer recipients.
Mega-rounds are changing the average
Six of Europe’s ten largest transactions in the first half exceeded €1 billion, according to Tech.eu. The list was concentrated in cloud infrastructure, AI, robotics and other businesses that need substantial upfront capital. Pure Data Centres’ €2.3 billion debt financing and Isomorphic Labs’ €1.8 billion Series B led the ranking.
Debt for infrastructure and equity for a research-heavy AI company are economically different, which is why aggregate funding should be read carefully. Both can lift the total without improving conditions for a seed-stage software founder. Median round sizes, new company formations and the distribution of capital by stage can reveal more than the headline sum alone.
AI was the largest vertical in Tech.eu’s figures with €5.9 billion, ahead of fintech at €4.7 billion and healthtech at €4.3 billion. Other market estimates that use broader definitions of AI exposure put its share much higher. The boundary is increasingly hard to draw because software, biotech, robotics and infrastructure companies now describe AI as a core capability.
Geography is concentrating alongside sector
The UK captured €18.7 billion across 423 deals in the first half, more than three times Germany’s €6.3 billion. France followed with €6 billion from 132 transactions. Sweden, the Netherlands and Spain formed the next group. Six of the ten largest rounds went to British companies.
This concentration reflects the UK’s deep investor base, large research institutions and ability to host capital-intensive infrastructure. It also means a small number of national and sector leaders can dominate Europe’s performance. A record-sized round in London does little for a young company trying to raise in a smaller regional ecosystem.
More than 6,410 investors participated in Tech.eu’s H1 count, so the issue is not that capital providers have disappeared. Investors are selecting more aggressively, reserving larger amounts for businesses that already demonstrate technical differentiation, strong revenue or the ability to absorb huge infrastructure spending. That behavior can be rational after the loose pricing of 2021 and 2022, but it reduces the number of experiments the market finances.
AI concentration creates second-order risks
AI companies often need costly computing, specialized talent and long research cycles. Large rounds can be appropriate. The risk is that investors treat the category as a substitute for diligence, funding similar model wrappers or forecasts built on declining compute costs without testing customer economics. Capital concentration can also raise entry barriers if a few companies lock up data, chips and researchers.
For non-AI founders, the reset changes positioning. Adding an AI label is unlikely to overcome weak unit economics, while companies with durable customer demand may benefit when competitors struggle to raise. Capital-efficient businesses can gain bargaining power if they reach milestones without depending on repeated rounds.
Limited deal volume also affects the pipeline of future scaleups. Venture portfolios rely on many early bets because only a minority produce exceptional returns. If seed and Series A activity remains depressed, Europe’s strong late-stage totals could be followed by fewer mature candidates several years from now.
A healthier market needs broader evidence
The first-half numbers are neither a simple recovery nor a collapse. Higher funding suggests that large European technology companies and infrastructure projects can still attract global capital. Lower deal count shows that access has become more selective, with AI reinforcing the divide.
Policymakers should avoid responding only with larger headline funds. University commercialization, cross-border hiring, procurement, pension-fund participation and liquid exit markets all influence whether more companies become investable. Founders, meanwhile, need to distinguish demand created by an AI budget cycle from recurring value customers will continue to buy.
Europe’s venture market currently rewards scale and scarcity. The next measure of health will be whether that capital produces enduring companies while enough smaller rounds continue to finance the next cohort. Without that breadth, impressive totals will describe a few winners rather than a functioning startup economy.
